Literature DB >> 1736012

Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.

P Fenaux1, P Jonveaux, I Quiquandon, C Preudhomme, J L Lai, M Vanrumbeke, M H Loucheux-Lefebvre, F Bauters, R Berger, J P Kerckaert.   

Abstract

Exons 5 to 8 of the p53 gene were examined for mutations in 60 patients with B-cell acute lymphoblastic leukemia (ALL), including 50 cases of precursor-B-cell ALL, nine cases of Burkitt (L3) ALL and one case of atypical ALL with surface immunoglobulins and t(8:14) translocation but L2 morphology. Karyotype was available in all patients. DNA was analyzed by polymerase chain reaction, single strand conformation polymorphism analysis, and nucleotide sequencing. Three patients showed point mutations in exons 7 or 8, including two of the nine patients with Burkitt ALL and one of the 50 patients with precursor-B-cell ALL. These findings suggest that p53 gene mutations are rare in precursor-B-cell ALL but may be more frequent in Burkitt ALL. In the three patients with p53 mutations, however, the relevance of those mutations to the development or progression of leukemia remained uncertain.

Entities:  

Mesh:

Year:  1992        PMID: 1736012

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

1.  Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.

Authors:  Majid Safa; Behnaz Tavasoli; Rima Manafi; Fatemeh Kiani; Meysam Kashiri; Saber Ebrahimi; Ahmad Kazemi
Journal:  Tumour Biol       Date:  2015-01-15

2.  Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

Authors:  Nina Richartz; Eva Duthil; Anthony Ford; Elin Hallan Naderi; Sampada Bhagwat; Karin M Gilljam; Marta Maria Burman; Ellen Ruud; Heidi Kiil Blomhoff; Seham Skah
Journal:  Blood Adv       Date:  2019-11-12

3.  Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.

Authors:  Angela D Bhalla; Sharon M Landers; Anand K Singh; Jace P Landry; Michelle G Yeagley; Gabryella S B Myerson; Cristian B Delgado-Baez; Stephanie Dunnand; Theresa Nguyen; Xiaoyan Ma; Svetlana Bolshakov; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Xizeng Mao; Xingzhi Song; Alexander J Lazar; Ian E McCutcheon; John M Slopis; Joseph A Ludwig; Dina C Lev; Kunal Rai; Keila E Torres
Journal:  Lab Invest       Date:  2022-02-28       Impact factor: 5.662

4.  MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2.

Authors:  L Gu; N Zhu; H W Findley; M Zhou
Journal:  Leukemia       Date:  2008-02-14       Impact factor: 11.528

5.  Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

Authors:  A Y Matsushima; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

6.  Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death.

Authors:  Martine M Kloster; Elin H Naderi; Harald Carlsen; Heidi K Blomhoff; Soheil Naderi
Journal:  Mol Cancer       Date:  2011-04-21       Impact factor: 27.401

7.  Targeting survivin and p53 in pediatric acute lymphoblastic leukemia.

Authors:  J W Tyner; A M Jemal; M Thayer; B J Druker; B H Chang
Journal:  Leukemia       Date:  2011-09-30       Impact factor: 11.528

8.  Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.

Authors:  Elin Hallan Naderi; Seham Skah; Hege Ugland; Ola Myklebost; Dagny Lise Sandnes; Maria Lyngaas Torgersen; Dag Josefsen; Ellen Ruud; Soheil Naderi; Heidi Kiil Blomhoff
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

9.  Induction of Cell Death in the Human Acute Lymphoblastic Leukemia Cell Line Reh by Infection with Rotavirus Isolate Wt1-5.

Authors:  Rafael Guerrero; Carlos Guerrero; Orlando Acosta
Journal:  Biomedicines       Date:  2020-07-24

10.  cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53.

Authors:  Seham Skah; Nina Richartz; Eva Duthil; Karin M Gilljam; Christian Bindesbøll; Elin Hallan Naderi; Agnete B Eriksen; Ellen Ruud; Marta M Dirdal; Anne Simonsen; Heidi Kiil Blomhoff
Journal:  Oncotarget       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.